Literature DB >> 16895503

Impact of postoperative infections on survival in colon cancer patients.

Angelo Nespoli1, Luca Gianotti, Giorgio Bovo, Fernando Brivio, Luca Nespoli, Mauro Totis.   

Abstract

PURPOSE: We investigated the prognostic significance of postoperative infections for the outcome of 192 patients with colon cancer.
METHODS: The 5-year survival rates were analyzed by the Kaplan-Meier technique. Univariate and multivariate analyses were done to evaluate prognostic variables using Cox's proportional hazard model.
RESULTS: Forty-three patients developed deep incisional or organ/space surgical site infections. The groups with and without infection were comparable. Multivariate analysis showed that only Dukes' stage (p=0.048) and postoperative infection (p=0.011) were independently associated with outcome. In patients with infective complications, the survival rate was significantly lower than in subjects without infection (log rank p=0.0004).
CONCLUSIONS: These results stress the importance of evaluating variables other than the classical tumor stage in predicting long-term cancer outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16895503     DOI: 10.1089/sur.2006.7.s2-41

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  8 in total

1.  Crohn's disease but not diverticulitis is an independent risk factor for surgical site infections in colectomy.

Authors:  Matthew Wideroff; Yunfan Xing; Junlin Liao; John C Byrn
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

2.  Bacterial contamination of hospital bed-control handsets in a surgical setting: a potential marker of contamination of the healthcare environment.

Authors:  R R W Brady; P Kalima; N N Damani; R G Wilson; M G Dunlop
Journal:  Ann R Coll Surg Engl       Date:  2007-10       Impact factor: 1.891

3.  Elevated preoperative C-reactive protein levels are a risk factor for the development of postoperative infectious complications following elective colorectal surgery.

Authors:  Toru Kubo; Satoshi Ono; Hideki Ueno; Eiji Shinto; Junji Yamamoto; Kazuo Hase
Journal:  Langenbecks Arch Surg       Date:  2013-08-29       Impact factor: 3.445

Review 4.  Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence.

Authors:  S D Gowing; J J Cool-Lartigue; J D Spicer; A J E Seely; L E Ferri
Journal:  Clin Exp Metastasis       Date:  2020-01-23       Impact factor: 5.150

5.  Incidence of Perioperative Complications Following Resection of Adrenocortical Carcinoma and Its Association with Long-Term Survival.

Authors:  Georgios Antonios Margonis; Neda Amini; Yuhree Kim; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Douglas B Evans; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Lindsey E Moses; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

Review 6.  Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery.

Authors:  S Gaines; C Shao; N Hyman; J C Alverdy
Journal:  Br J Surg       Date:  2018-01       Impact factor: 6.939

7.  Use of gentamicin-collagen sponge (Collatamp® G) in minimally invasive colorectal cancer surgery: A propensity score-matched study.

Authors:  Kil-Yong Lee; Jaeim Lee; Youn Young Park; Seong Taek Oh
Journal:  PLoS One       Date:  2022-03-28       Impact factor: 3.240

8.  Environmental risk factors for relapse of melanoma.

Authors:  Samantha Beswick; Paul Affleck; Faye Elliott; Edwina Gerry; Andy Boon; Linda Bale; Clarissa Nolan; Jennifer H Barrett; Chandra Bertram; Jerry Marsden; D Timothy Bishop; Julia A Newton-Bishop
Journal:  Eur J Cancer       Date:  2008-07-02       Impact factor: 9.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.